Table 3.
Genotype/allelea | Controls (n) | Cases (n) | P |
---|---|---|---|
5/5 | 28 (5.0) | 15 (3.1) | 0.927b |
6/5 | 13 (2.3) | 9 (1.9) | – |
6/6 | 4 (0.7) | 1 (0.2) | – |
9/5 | 10 (1.8) | 13 (2.7) | – |
9/6 | 6 (1.1) | 9 (1.9) | – |
9/9 | 13 (2.3) | 15 (3.1) | – |
7/5 | 110 (19.6) | 83 (17.4) | 0.362c |
7/6 | 62 (11.1) | 41 (8.6) | 0.187c |
7/7 | 206 (36.7) | 183 (38.4) | 0.585c |
9/7 | 109 (19.4) | 108 (22.7) | 0.205c |
Total | 561 | 477 | |
5 | 189 (16.8) | 135 (14.1) | 0.092c |
6 | 89 (7.9) | 61 (6.4) | 0.177c |
7 | 693 (61.8) | 598 (62.7) | 0.667c |
9d | 151 (13.5) | 160 (16.8) | 0.035c |
Total | 1,122 | 954 |
Notes: Values are n (%).
The number refers to the number of neck region repeats encoded by each genotype or allele.
Chi-squared test for the merged group of 5/5, 6/5, 6/6, 9/5, 9/6, 9/9, each genotype frequency of which is <5%.
Chi-squared test.
P<0.05. The significant value is shown in bold.
Abbreviations: DC-SIGNR, dendritic cell-specific intercellular adhesion molecule-3 grabbing nonintegrin-related; NPC, nasopharyngeal carcinoma.